The Structural Convergence of Care Management and Remote Monitoring: A Strategic Valuation of ChartSpan’s Acquisition of Validic

Nelson Advisors
5 hours ago
8 min read

On June 22nd, 2026, ChartSpan Medical Technologies finalised its strategic acquisition of Validic, a prominent personal health data and healthcare Internet of Things (IoT) platform. Operating as a consolidated entity under the ChartSpan banner, the transaction establishes a unified clinical delivery layer that merges full-service virtual care teams with a scaled device-logistics and data normalisation ecosystem.

The transaction bridges a historically fragmented healthcare data gap by combining traditional Chronic Care Management (CCM) and Advanced Primary Care Management (APCM) with continuous, home-based Remote Patient Monitoring (RPM).

Transaction Overview and Financial Underpinnings

While the transaction’s absolute dollar valuation was not publicly disclosed, the acquisition was supported by structured institutional financing led by BIP Capital. The investment firm’s efforts were directed by Managing Partner and CEO Mark Buffington alongside Principal RT Wyatt. Securities and Exchange Commission (SEC) filings reveal that a specialised Delaware-incorporated entity named BIP Ventures ChartSpan Equity I-QP, LLC (CIK: 0002126958) was registered in 2026 to facilitate the capitalisation. The entity initiated a pooled investment offering of $15,100,000 on June 2, 2026, with $6,890,000 in equity sold as of mid-June 2026.

To execute the transaction, Validic retained Oppenheimer & Co. Inc. as its exclusive financial advisor. Prior to the acquisition, both organisations maintained independent, highly capitalised trajectories. ChartSpan had accumulated $37.1 million across six funding rounds, notably anchored by a $15 million Series A round in June 2019 led by BIP Capital, which led to the appointment of BIP Capital's Sarath Degala to ChartSpan’s Board of Directors. Validic had secured $31.6 million across eight investment rounds, backed by institutional investors including Kaiser Permanente Ventures, SJF Ventures, and Greycroft.

Capitalisation and Financial Parameters	ChartSpan Medical Technologies	Validic, Inc.	Consolidated Organization
Total Venture Funding Raised	$37.1 Million	$31.6 Million	Structured consolidated debt & equity capital
Primary Institutional Backers	BIP Capital, Blue Heron Capital, Cypress Growth Capital	Kaiser Permanente Ventures, SJF Ventures, Greycroft	BIP Capital, BIP Ventures, and historic investors
Lead Investment Advisors	Croft & Bender (historic)	Oppenheimer & Co. Inc.	Oppenheimer & Co. Inc. and BIP Capital
Transaction Structure	Corporate Acquirer	Acquired Subsidiary	Merged operating unit under ChartSpan brand

Historical Trajectories and Strategic Positioning

ChartSpan was co-founded in 2012 by Jon-Michial Carter, his brother, and a third unnamed co-founder in Greenville, South Carolina. The startup emerged from The Iron Yard accelerator, initially focusing on a patient-facing mobile application designed to digitize paper-based medical charts through mobile optical character recognition. Recognizing structural shifts in federal reimbursement,

ChartSpan pivoted to become the largest provider of managed Chronic Care Management services in the United States. Under the executive leadership of Chief Executive Officer Christine Hawkins, the company deployed specialised clinical software and an expansive, 24/7 virtual nursing workforce to manage high-risk Medicare populations. ChartSpan achieved strong performance metrics, including average patient enrollment rates of 45% in primary care practices and 35% in specialty practices, supported by complimentary Merit-based Incentive Payment System (MIPS) and quality improvement services for its clients.

Validic was founded in 2010 by Drew Schiller and Ryan Beckland in Durham, North Carolina, as a pioneer in patient-generated health data aggregation. Operating as a platform-as-a-service (PaaS) model, Validic’s core database normalized and integrated biomedical telemetry from hundreds of disparate clinical and consumer devices. By 2026, the company’s platform reached over 223 million lives across 52 countries.

A major turning point in Validic's operational history occurred on May 15th, 2023, when the company acquired the assets of Trapollo LLC, a connected health and device logistics provider, from its parent company, Cox Communications. This acquisition integrated Trapollo's fulfillment center in Sterling, Virginia, directly into Validic's operations. Steve Nester, the former General Manager of Trapollo, transitioned to Senior Vice President and General Manager of Validic’s logistics division.

The integration of Trapollo enabled Validic to manage the entire device lifecycle, including inventory management, configuration, delivery of pre-paired medical kits, and patient technical onboarding. This operational capability was demonstrated in its joint program with Kaiser Permanente on the West Coast, which supported over 300,000 enrolled patients. This scale of clinical and device logistics integration yielded documented, high-precision clinical outcomes across large populations.

Clinical & Operational Metrics	Kaiser Permanente & Joint Program Baseline Outcomes
Enrolled Population (West Coast)	300,000+ patients since program inception
Glycated Hemoglobin (A1C) Control	1.2 point absolute reduction within a 90-day period for diabetic patients
Systolic Blood Pressure (SBP) Control	12% drop in SBP in 45 days, transitioning stage 2 hypertension to normal
Clinical Efficiency Rate	88% of participating clinicians reported saved administrative and active clinical time
Clinician-Patient Communication	63% reduction in phone call times, from an average of 15 minutes to 5.5 minutes
Patient Adherence and Engagement	76% of enrolled patients maintained biometric readings at least twice daily after 90 days
Patient Care Satisfaction Score	75% of active participants reported feeling they were receiving superior, highly personal care

Technical Integration and Product Infrastructure

The combined platform combines Validic's two primary product categories, Validic Inform and Validic Impact, directly with ChartSpan’s care orchestration workflows. Validic Inform acts as a persistent, standardised data infrastructure layer. Rather than requiring hospital IT teams to build separate API integrations for different medical hardware brands, the Inform platform normalises streams from over 700 consumer and clinical-grade devices into a unified, developer-friendly interface. The system operates across a wide array of technical interfaces, providing developers with REST APIs, real-time streaming services, native iOS and Android SDKs, and push notification architectures.

Validic Impact builds upon this normalization engine to deliver a turnkey, clinical-facing application integrated directly into electronic health records (EHRs) such as Epic and Oracle Health (Cerner). By writing biometric data directly to EHR flowsheets, clinical charts, and in-basket routing systems, the platform minimizes the administrative burden on clinical staff.

When combined with ChartSpan’s human capital, this integration changes the delivery of remote care. Instead of practicing blind, periodic monthly outreach, ChartSpan’s care managers can review continuous physiological data and respond to automatic alerts triggered by patient devices. This continuous clinical triage allows care teams to address physiological decompensation in real time, preventing conditions from worsening into emergencies.

Regulatory Compliance and Reimbursement Economics under CMS Guideline Revisions

The financial and operational rationale for combining CCM, APCM, and RPM services is reinforced by updates in the Medicare Physician Fee Schedule (PFS). Historically, primary care groups struggled with the administrative burden of tracking staff minutes for Chronic Care Management billing. To address this friction, CMS introduced Advanced Primary Care Management (APCM) on January 1st, 2025, as an activity-based monthly bundle comprising 13 structural service elements. APCM consolidates the care coordination goals of CCM, Principal Care Management (PCM), and Transitional Care Management (TCM) into a single, non-time-based billing structure.

In the CY 2026 Physician Fee Schedule, CMS increased reimbursement rates by approximately 10% across the three base APCM G-codes (G0556, G0557, G0558). In addition, CMS finalised three new behavioral health integration (BHI) add-on codes, G0568, G0569, and G0570, designed to support the Psychiatric Collaborative Care Model (CoCM) and general BHI within primary care workflows without requiring time-based documentation. Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) have also transitioned to these codes, billing individual APCM codes at national non-facility PFS rates.

HCPCS Billing Code	Risk & Complexity Level	Qualifying Patient Profile	2025 National Rate	2026 National Rate	Key Reimbursement Guidelines
G0556	Level 1 APCM	Patients diagnosed with 0 to 1 chronic condition.	$15.00	~$16.00	Requires verbal/written patient consent; primary care provider only.
G0557	Level 2 APCM	Patients diagnosed with $\ge 2$ complex chronic conditions.	$49.00	~$54.00	Conditions must last $\ge 12$ months, posing significant risk of acute decline.
G0558	Level 3 APCM	Level 2 clinical criteria + Qualified Medicare Beneficiary (QMB) status.	$107.00	~$117.00	Intended for dual-eligible populations with state-covered copays.
G0568	CoCM Add-on	Initial month of Collaborative Care Model services.	N/A	~$162.00	Billed alongside base APCM codes; mirrors CPT 99492 but without time tracking.
G0569	CoCM Add-on	Subsequent months of Collaborative Care Model services.	N/A	~$146.00	Billed alongside base APCM codes; mirrors CPT 99493 but without time tracking.
G0570	General BHI Add-on	Continuous general Behavioral Health Integration.	N/A	~$57.00	Billed alongside base APCM codes; mirrors CPT 99484 but without time tracking.

Under CMS regulations, APCM and traditional CCM codes are mutually exclusive for the same patient in the same billing month. However, providers are explicitly permitted to bill either APCM or CCM concurrently with Remote Patient Monitoring (RPM).

To bill both services concurrently and maintain compliance during audits, clinical teams must adhere to strict guidelines. First, both programs must independently satisfy their respective CMS criteria. No clinical activity minutes may be double-counted; the time a care team spends coordinating chronic care (CCM) cannot be counted toward the time a clinician spends reviewing physiological data (RPM).

For new patients, an initiating face-to-face visit, such as an Annual Wellness Visit (AWV) or standard Evaluation and Management (E/M) service, is required to discuss and obtain separate consent for each program. The RPM component requires the patient to use an FDA-defined medical device that automatically transmits physiological measurements, recording a minimum of 16 days of readings in a 30-day period (CPT 99454). Additionally, the care team must spend a distinct 20 minutes per month performing clinical data review and interactive communication (CPT 99457).

Market Expansion and Enterprise Commercial Strategy

The acquisition of Validic transforms ChartSpan’s commercial model from a clinic-focused care provider into a multi-sided enterprise digital health platform. Traditionally, ChartSpan’s client footprint was concentrated in independent primary care practices. By integrating Validic’s assets, the combined organisation can expand its commercial target footprint to serve health systems, commercial payers, digital health innovators and life sciences companies.

For health systems and Accountable Care Organizations (ACOs), the consolidated platform addresses the operational fragmentation caused by managing multiple digital health point-solutions. Instead of using separate vendors for care management, remote patient monitoring devices, patient onboarding and EHR software integration, health systems can deploy ChartSpan as a single, unified clinical and technological partner. This approach simplifies procurement, aligns clinical care teams, and lowers administrative overhead for hospital staff.

For payers and managed care organisations, the combined offering supports proactive risk management. By using home-based biometric telemetry, payers can identify physiological decompensation early and intervene before conditions worsen, helping to reduce expensive emergency room visits and hospital readmissions.

For digital health innovators and life sciences companies, the platform provides a scalable data infrastructure. Access to normalised real-world data (RWD) from over 20 Million connected lives can help life sciences organisations track long-term treatment efficacy, monitor medication adherence, and streamline decentralised clinical trial designs.

Strategic Implications and Future Outlook

The consolidation of ChartSpan and Validic represents a significant maturity milestone for the remote care industry. For over a decade, the health IT market operated in silos, with software vendors providing data connectivity and clinical organizations operating in isolation. This transaction directly addresses that fragmentation by combining a scaled health IoT platform and device logistics system with a dedicated clinical care workforce.

As CMS continues to transition toward value-based reimbursement models, such as Advanced Primary Care Management, the demand for integrated, continuous remote care is expected to rise. By leveraging its in-house device logistics, real-time data normalization, and 24/7 virtual care teams, the combined entity is well-positioned to lead this shift. This unified approach helps healthcare organizations move beyond periodic, episodic patient observations to establish a model of continuous clinical understanding.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech